Factors Related to In-hospital Deaths in Patients With Tuberculosis
Authors:
- Stella PendleSPStella Pendle
Open Access
- 28 September 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 158 (17) , 1916-1922
Abstract
ALMOST 90 million new cases of tuberculosis (TB) worldwide have been predicted for the decade of 1990 through 1999.1 This astronomical figure reflects the failure to control the disease despite the availability of effective antimicrobials. The specter of TB has become even more threatening in the face of burgeoning multidrug resistance and large numbers of individuals rendered susceptible to the disease by human immunodeficiency virus (HIV) infection. Increasing evidence is accumulating to support the pivotal role of host immunity2 and cytokine kinetics3 in individual responses to the infection. A large percentage of individuals fail to develop the disease at all despite exposure.4 Others develop extensive and often uncontrolled pulmonary and extrapulmonary spread. This may be because of compromised immunity. However, in a substantial number of seemingly immunocompetent patients, the reasons for dissemination are not clear.5 Attempts have been made to implicate environmental and hereditary factors.6,7 While several predisposing conditions such as HIV disease, steroid treatment, and diabetes have been well characterized, many patients with aggressive disease appear to be otherwise immunologically normal.Keywords
This publication has 13 references indexed in Scilit:
- A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for TuberculosisNew England Journal of Medicine, 1997
- Immune activation, allergic drug toxicity and mortality in HIV-positive tuberculosisTubercle and Lung Disease, 1996
- Influence of HLA-DR and -DQ phenotypes on tuberculin reactive status in pulmonary tuberculosis patientsTubercle and Lung Disease, 1996
- Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patientsTubercle and Lung Disease, 1996
- Cavitary Pulmonary Lesions in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- Clinical features of HIV seropositive and HIV seronegative patients with tuberculous lymphadenitis in Dar es SalaamTubercle and Lung Disease, 1995
- Why do our patients die of active tuberculosis in the era of effective therapy?Tubercle and Lung Disease, 1994
- The mortality and pathology of HIV infection in a West African cityAIDS, 1993
- Treatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Use of Mycobacterial Smears in the Diagnosis of Pulmonary Tuberculosis in AIDS/ARC PatientsChest, 1989